menu search

RDHL / Why Is Redhill Biopharma (RDHL) Stock Up 32% Today?

Why Is Redhill Biopharma (RDHL) Stock Up 32% Today?
Redhill Biopharma (NASDAQ: RDHL ) stock is rocketing higher on Friday after getting positive patent news from the U.S. Patent and Trademark Office (USPTO). The USPTO issued a Notice of Allowance that grants the company a patent for RHB-204's treatment methods. Read More
Posted: Jan 27 2023, 07:46
Author Name: InvestorPlace
Views: 103151

RDHL News  

RedHill Biopharma's stock soars 10% after company gets U.S. funding to develop treatment for radiation sickness

By Market Watch
July 21, 2023

RedHill Biopharma's stock soars 10% after company gets U.S. funding to develop treatment for radiation sickness

RedHill Biopharma Ltd.'s stock RDHL, +1.65% soared 10% premarket after the company said it has received a further $1.7 million in U.S. government fund more_horizontal

The Impact of Market Trends on Penny Stocks Performance

By PennyStocks
January 28, 2023

The Impact of Market Trends on Penny Stocks Performance

Understand how market trends impact penny stocks The post The Impact of Market Trends on Penny Stocks Performance  appeared first on Penny Stocks to more_horizontal

Why Is Redhill Biopharma (RDHL) Stock Up 32% Today?

By InvestorPlace
January 27, 2023

Why Is Redhill Biopharma (RDHL) Stock Up 32% Today?

Redhill Biopharma (NASDAQ: RDHL ) stock is rocketing higher on Friday after getting positive patent news from the U.S. Patent and Trademark Office (US more_horizontal

Hot Penny Stocks to Buy Right Now? Check These 3 Out

By PennyStocks
June 24, 2022

Hot Penny Stocks to Buy Right Now? Check These 3 Out

Can these penny stocks make gains this coming week? The post Hot Penny Stocks to Buy Right Now? more_horizontal

RedHill Biopharma Ltd. (RDHL) CEO Dror Ben-Asher on Q1 2022 Results - Earnings Call Transcript

By Seeking Alpha
June 23, 2022

RedHill Biopharma Ltd. (RDHL) CEO Dror Ben-Asher on Q1 2022 Results - Earnings Call Transcript

RedHill Biopharma Ltd. (NASDAQ:RDHL ) Q1 2022 Results Conference Call June 23, 2022 8:30 AM ET Company Participants Debbie Bechor - Business Developme more_horizontal

RedHill Biopharma to Host First Quarter 2022 Financial Results and Operational Highlights Webcast on June 23, 2022

By PRNewsWire
June 17, 2022

RedHill Biopharma to Host First Quarter 2022 Financial Results and Operational Highlights Webcast on June 23, 2022

TEL AVIV, Israel and RALEIGH, N.C. , June 17, 2022 /PRNewswire/ -- RedHill Biopharma Ltd. more_horizontal

RedHill Biopharma Ltd. (RDHL) CEO Dror Ben-Asher on Q4 2021 Results - Earnings Call Transcript

By Seeking Alpha
March 17, 2022

RedHill Biopharma Ltd. (RDHL) CEO Dror Ben-Asher on Q4 2021 Results - Earnings Call Transcript

RedHill Biopharma Ltd. (RDHL) CEO Dror Ben-Asher on Q4 2021 Results - Earnings Call Transcript more_horizontal

RedHill, Kukbo Ink Oral Opaganib Licensing Pact For COVID-19 In South Korea

By Benzinga
March 15, 2022

RedHill, Kukbo Ink Oral Opaganib Licensing Pact For COVID-19 In South Korea

RedHill Biopharma Ltd (NASDAQ: RDHL) has entered into an exclusive license agreement with Kukbo Co Ltd for oral opaganib to treat COVID-19 in Sou more_horizontal


Search within

Pages Search Results: